ZA200904329B - Pharmaceutical compositions and method for treating inflammation in cattle and other animals - Google Patents

Pharmaceutical compositions and method for treating inflammation in cattle and other animals

Info

Publication number
ZA200904329B
ZA200904329B ZA200904329A ZA200904329A ZA200904329B ZA 200904329 B ZA200904329 B ZA 200904329B ZA 200904329 A ZA200904329 A ZA 200904329A ZA 200904329 A ZA200904329 A ZA 200904329A ZA 200904329 B ZA200904329 B ZA 200904329B
Authority
ZA
South Africa
Prior art keywords
cattle
animals
pharmaceutical compositions
treating inflammation
inflammation
Prior art date
Application number
ZA200904329A
Other languages
English (en)
Inventor
Cheyney Meadows
Keith Alan Freehauf
Robert D Simmons
Allan J Weingarten
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of ZA200904329B publication Critical patent/ZA200904329B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200904329A 2006-12-20 2009-06-19 Pharmaceutical compositions and method for treating inflammation in cattle and other animals ZA200904329B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87090706P 2006-12-20 2006-12-20

Publications (1)

Publication Number Publication Date
ZA200904329B true ZA200904329B (en) 2010-05-26

Family

ID=39262615

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904329A ZA200904329B (en) 2006-12-20 2009-06-19 Pharmaceutical compositions and method for treating inflammation in cattle and other animals

Country Status (19)

Country Link
US (1) US9006272B2 (ru)
EP (1) EP2120860B1 (ru)
JP (1) JP5377326B2 (ru)
KR (1) KR20090091328A (ru)
CN (2) CN103690471B (ru)
AR (1) AR064425A1 (ru)
AU (1) AU2007339312B2 (ru)
BR (1) BRPI0720500B1 (ru)
CA (1) CA2672964C (ru)
CL (1) CL2007003711A1 (ru)
CO (1) CO6190598A2 (ru)
ES (1) ES2714550T3 (ru)
MX (1) MX2009006893A (ru)
NZ (1) NZ598554A (ru)
PE (1) PE20081406A1 (ru)
RU (1) RU2466715C2 (ru)
TW (1) TWI350182B (ru)
WO (1) WO2008082507A2 (ru)
ZA (1) ZA200904329B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010050889A1 (en) * 2008-10-31 2010-05-06 Moberg Derma Ab Topical composition comprising a combination of at least two penetration enhancing agents
WO2011112875A2 (en) 2010-03-10 2011-09-15 Nuvo Research Inc. Foamable formulation
WO2012022837A1 (en) * 2010-08-16 2012-02-23 Helsingin Yliopisto Transdermal compositions
CN103179970B (zh) * 2010-09-30 2015-11-25 富山化学工业株式会社 透皮吸收制剂
CN114903848A (zh) * 2013-02-27 2022-08-16 阿根塔创新有限公司 透皮制剂
CN105769827B (zh) * 2016-03-09 2018-07-17 金陵科技学院 用于动物清热镇痛氟尼辛葡甲胺涂膜剂及其制备方法
KR20200065711A (ko) 2018-11-30 2020-06-09 한원경 동물 피부질환 개선용 조성물
AU2020315758A1 (en) 2019-07-16 2022-02-10 Donaghys Limited Transdermal solvent system and methods of use
WO2021045870A1 (en) * 2019-09-06 2021-03-11 Iowa State University Research Foundation, Inc. Mirtazapine as a pre-shipping inhibitor of bovine respiratory disease
WO2022112277A1 (en) * 2020-11-25 2022-06-02 Intervet International B.V. Method of treatment of pain through buccal administration of flunixin
WO2022238965A1 (en) * 2021-05-12 2022-11-17 Argenta Innovation Limited Veterinary transdermal formulation
CN114404360B (zh) * 2021-12-16 2023-03-28 江西益昕葆生物科技有限公司 一种氟尼辛葡甲胺注射液的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63225316A (ja) * 1986-10-21 1988-09-20 Nitto Electric Ind Co Ltd 外皮投与用組成物
JPH11222443A (ja) * 1997-11-11 1999-08-17 Saitama Daiichi Seiyaku Kk 経皮吸収促進組成物および経皮吸収製剤
AU1780101A (en) * 1999-11-19 2001-05-30 Xel Herbaceuticals Transdermal delivery system for alkaloids of aconitum species
JP4865958B2 (ja) * 2001-05-23 2012-02-01 株式会社トクホン 鎮痛抗炎症局所作用型の貼付剤
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
CA2530407A1 (en) 2003-07-23 2005-02-03 The Regents Of The University Of California Penetration enhancer combinations for transdermal delivery
AU2004258745A1 (en) * 2003-07-31 2005-02-03 Pharmacia & Upjohn Company Llc Dispersible formulation of an anti-inflammatory agent
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
BRPI0513401A (pt) * 2004-07-19 2008-05-06 Warner Lambert Co formulação para estimular crescimento de cabelo
JP2008513388A (ja) * 2004-09-16 2008-05-01 バイエル・ヘルスケア・アクチェンゲゼルシャフト 動物の皮膚病を処置するための皮膚投与可能な製剤
KR20080071185A (ko) 2005-11-21 2008-08-01 쉐링-프라우 리미티드 부프레노르핀을 포함하는 약제학적 조성물

Also Published As

Publication number Publication date
US20080153885A1 (en) 2008-06-26
RU2466715C2 (ru) 2012-11-20
BRPI0720500B1 (pt) 2019-01-02
JP5377326B2 (ja) 2013-12-25
BRPI0720500A8 (pt) 2015-12-29
AU2007339312A1 (en) 2008-07-10
WO2008082507A3 (en) 2009-03-19
CN103690471A (zh) 2014-04-02
NZ598554A (en) 2013-08-30
CN103690471B (zh) 2015-11-18
PE20081406A1 (es) 2008-10-17
WO2008082507A2 (en) 2008-07-10
AU2007339312B2 (en) 2013-06-06
ES2714550T3 (es) 2019-05-29
CN101588789A (zh) 2009-11-25
TWI350182B (en) 2011-10-11
BRPI0720500A2 (pt) 2014-02-04
CL2007003711A1 (es) 2008-07-25
CN101588789B (zh) 2013-12-11
US9006272B2 (en) 2015-04-14
CA2672964A1 (en) 2008-07-10
EP2120860A2 (en) 2009-11-25
KR20090091328A (ko) 2009-08-27
TW200833367A (en) 2008-08-16
CO6190598A2 (es) 2010-08-19
MX2009006893A (es) 2009-07-03
JP2010513500A (ja) 2010-04-30
EP2120860B1 (en) 2019-01-23
CA2672964C (en) 2018-04-03
AR064425A1 (es) 2009-04-01
RU2009127500A (ru) 2011-01-27

Similar Documents

Publication Publication Date Title
TWI350182B (en) Pharmaceutical compositions and method for treating inflammation in cattle and other animals
IL291175A (en) Compositions and methods for treating collagen-mediated diseases
IL230759A (en) The vehicle containing anilide noble is preserved and its uses in farm animals
HK1184697A1 (zh) 用於治療炎症和自體免疫疾病的組合物和方法
EP2214707A4 (en) COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION
IL193421A0 (en) Methods and compositions for increased productivity in animals
ZA201008810B (en) Pharmaceutical transdermal compositions and method for treating inflammation in cattle
HUP0700369D0 (en) Pharmaceutical compositions and method for treating schizofrenia
ZA201104062B (en) Compositions and methods for controlling disease in animals
ZA200906541B (en) Compositions and methods for preventing or treating obesity in animals
HK1245679A1 (zh) 用於治療皮膚疾病和病症的方法和組合物
IL198723A0 (en) Methods and compositions for therapeutic treatment
HK1117993A1 (en) Method for treating and preventing scuticociliatosis in fishes
ZA201305125B (en) Compositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyperthyroidism
HU0700370D0 (en) Pharmaceutical compositions and method for treating acuse mania
GB0622582D0 (en) Animal feeds and veterinary compositions
EP2056849A4 (en) METHODS AND COMPOSITIONS FOR TREATING IGE MEDIATED DISEASES
IL193289A0 (en) Compositions and methods for treating lysosomal storage diseases
ZA200806361B (en) Methods and compositions for treating feline hyperthyroidism
EP2057179A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF MYELOSUPPRESSION
PL3156057T3 (pl) Powlekany delmopinolem gryzak dla zwierząt do stosowania w zapobieganiu lub leczeniu halitozy
BRPI0923301A2 (pt) "método e composições para o aprimoramento de plantas"
EP2351558A4 (en) THERAPEUTIC AGENT AGAINST TYMPANITES IN REPURITISHES
EP2004164A4 (en) PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING DEGENERATIVE DISORDERS OR INFLAMMATORY DISORDERS
GB0718918D0 (en) Compositions and methods for treating skin conditions